SHC
NASDAQSotera Health Company
Price$15.63-0.12 (-0.73%)
2026-03-042026-06-05
News · 26 weeks68+14%
2025-12-142026-06-07
Mix4290d
- Insider21(50%)
- SEC Filings9(21%)
- Other7(17%)
- Offering2(5%)
- Earnings2(5%)
- Analyst1(2%)
Latest news
25 items- ANALYSTGoldman initiated coverage on Sotera Health with a new price targetGoldman initiated coverage of Sotera Health with a rating of Buy and set a new price target of $20.00
- SECSEC Form SD filed by Sotera Health CompanySD - Sotera Health Co (0001822479) (Filer)
- INSIDERDirector Klee Ann R. was granted 14,970 shares, increasing direct ownership by 12% to 140,926 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERChief Executive Officer Shader Alton was granted 579,573 shares (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERSEC Form 3 filed by new insider Shader Alton3 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Kyle Richard G was granted 14,970 shares (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Krause Kenneth D. was granted 14,970 shares (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Cunningham Sean Laurence was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Flynn Karen was granted 14,970 shares, increasing direct ownership by 38% to 54,191 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Neary James was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Petrella Vincent K was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Chen Ruoxi was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Simon, Christopher was granted 14,970 shares, increasing direct ownership by 78% to 34,102 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Wheadon David E. was granted 14,970 shares, increasing direct ownership by 20% to 89,882 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- SECSotera Health Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Sotera Health Co (0001822479) (Filer)
- SECSotera Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - Sotera Health Co (0001822479) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Sotera Health CompanySCHEDULE 13G/A - Sotera Health Co (0001822479) (Subject)
- INSIDERDirector Warburg Pincus & Co. sold $289,753,576 worth of shares (19,102,952 units at $15.17) (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Warburg Pincus & Co. sold $289,753,576 worth of shares (19,102,952 units at $15.17) (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Gtcr Investment Xi Llc sold $193,169,046 worth of shares (12,735,301 units at $15.17) (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- SECSotera Health Company filed SEC Form 8-K: Other Events, Termination of a Material Definitive Agreement8-K - Sotera Health Co (0001822479) (Filer)
- SECSEC Form 424B7 filed by Sotera Health Company424B7 - Sotera Health Co (0001822479) (Filer)
- SECSEC Form 424B7 filed by Sotera Health Company424B7 - Sotera Health Co (0001822479) (Filer)
- PRSotera Health Announces Secondary Offering of Common StockCLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 31,838,253 shares of its common stock, par value $0.01 per share. All 31,838,253 shares are being offered for sale by certain affiliates of Warburg Pincus LLC ("Warburg Pincus") and GTCR LLC ("GTCR") as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Registra
- SECSEC Form 10-Q filed by Sotera Health Company10-Q - Sotera Health Co (0001822479) (Filer)
SHC FAQ
7 questionsWhat does Sotera Health Company do?
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly...Where does SHC stock trade?
Sotera Health Company (SHC) is listed on NASDAQ.What sector and industry is SHC in?
Sotera Health Company operates in the Health Care sector, Misc Health and Biotechnology Services industry.When did Sotera Health Company go public?
Sotera Health Company (SHC) completed its IPO in 2020.What are analysts saying about SHC?
Sotera Health Company has had 8 recent analyst actions on file. The most recent action was from Goldman: Buy with a $2000.00 price target on 2026-06-05. Recent price targets range from $1300.00 to $2400.00.What companies are similar to SHC?
Notable peers in the same industry include DVA (DaVita Inc.), FMS (Fresenius Medical Care AG), PGNY (Progyny Inc.), AGL (agilon health inc.), VMD (Viemed Healthcare Inc.). Compare SHC side-by-side with any of them on Quantisnow.How can I track SHC on Quantisnow?
Quantisnow aggregates Sotera Health Company's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SHC to receive live email and push alerts on every new disclosure.